Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
t-cell symbols : Qgen save search
Denovo Biopharma and QIAGEN partner to develop companion diagnostic test for the treatment of Diffuse Large B-Cell Lymphoma (DLBCL)
Published: 2021-12-09 (Crawled : 19:00) - biospace.com/
QGEN | $41.89 1.63% 0.0% 900K
|
Health Technology
|
| O: 0.82%
H: 0.29%
C: -1.35%
QGEN | $41.89 1.63% 0.0% 900K
|
Health Technology
|
| O: 0.82%
H: 0.29%
C: -1.35%
diagnostic treatment biopharma test t-cell
QIAGEN and Denovo Biopharma Partner to Develop Companion Diagnostic Test for the Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)
Published: 2021-12-09 (Crawled : 08:00) - biospace.com/
QGEN | $41.89 1.63% 0.0% 900K
|
Health Technology
|
| O: 0.82%
H: 0.29%
C: -1.35%
QGEN | $41.89 1.63% 0.0% 900K
|
Health Technology
|
| O: 0.82%
H: 0.29%
C: -1.35%
diagnostic treatment biopharma test t-cell
QIAGEN Launches CE-marked Version of QuantiFERON® SARS-CoV-2 to Assess T-cell Response to COVID-19
Published: 2021-12-02 (Crawled : 09:00) - biospace.com/
QGEN | $41.89 1.63% 0.0% 900K
|
Health Technology
|
| O: 0.78%
H: 0.88%
C: 0.5%
QGEN | $41.89 1.63% 0.0% 900K
|
Health Technology
|
| O: 0.78%
H: 0.88%
C: 0.5%
covid quantiferon t-cell sars-cov-2 response
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.